Detailansicht

Wissensnetz

Person

Heinz Wiendl (1968-)

Neurologe

Name	Heinz Wiendl
Zeit	1968- (Lebensdaten)
Ort	Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Neurologe (charakteristischer Beruf)
Variante	H. Wiendl
Beziehung	Universitätsklinikum Münster. Department für Neurologie (2010-)
Themengebiet	Personen zu Medizin, Tiermedizin
Weitere Angaben	Professor für Neurologie in Würzburg
Quelle	Wikipedia: https://de.wikipedia.org/wiki/Heinz_Wiendl (Stand: 12.08.2021)
Datensatztyp	Person
GND-Nummer	131501097
Datensatz-ID	131501097
Beteiligt an alle anzeigen Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas CNS Pericytes Modulate Local T Cell Infiltration in EAE Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses Humoral signatures of MOG-antibody-associated disease track with age and disease activity Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease : A Case Series Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report Stroke induces disease-specific myeloid cells in the brain parenchyma and pia Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies Bilaterality of temporal EEG findings in limbic encephalitis compared to other mesiotemporal epilepsies: a retrospective cohort study. Eculizumab versus rituximab in generalised myasthenia gravis Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients Profiling Complement System Components in Primary CNS Vasculitis Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation Multiple Sklerose : Klinik, Diagnostik und Therapie Multiple Sklerose : Klinik, Diagnostik und Therapie Multiple Sklerose : Klinik, Diagnostik und Therapie Ofatumumab : neue Perspektiven für eine zielgerichtete Therapie der aktiven schubförmigen multiplen Sklerose Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD Blood and cerebrospinal fluid immune cell profiles in patients with temporal lobe epilepsy of different etiologies. Genetic determinants of the humoral immune response in MS Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation Cerebrospinal fluid concentrations of neuronal proteins are reduced in primary angiitis of the central nervous system Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen Fragen und Antworten zur Neuroimmunologie Impaired Autonomic Responses to Emotional Stimuli in Autoimmune Limbic Encephalitis Excitotoxic neuronal cell death during an oligodendrocyte-directed CD8+T cell attack in the CNS gray matter Alemtuzumab : humanisierter monoklonaler Antikörper in der MS-Therapie

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Heinz Wiendl (1968-)

Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis

Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment

Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response

Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry

Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas

CNS Pericytes Modulate Local T Cell Infiltration in EAE

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort

High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses

Humoral signatures of MOG-antibody-associated disease track with age and disease activity

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients

Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease : A Case Series

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma

Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments

Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters

MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD

MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD

Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis

Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report

Stroke induces disease-specific myeloid cells in the brain parenchyma and pia

Therapie und Verlauf neurologischer Erkrankungen

Therapie und Verlauf neurologischer Erkrankungen

Therapie und Verlauf neurologischer Erkrankungen

Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma

Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses

Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report

Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies

Bilaterality of temporal EEG findings in limbic encephalitis compared to other mesiotemporal epilepsies: a retrospective cohort study.

Eculizumab versus rituximab in generalised myasthenia gravis

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients

Profiling Complement System Components in Primary CNS Vasculitis

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions

Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments

Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation

Multiple Sklerose : Klinik, Diagnostik und Therapie

Multiple Sklerose : Klinik, Diagnostik und Therapie

Multiple Sklerose : Klinik, Diagnostik und Therapie

Ofatumumab : neue Perspektiven für eine zielgerichtete Therapie der aktiven schubförmigen multiplen Sklerose

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets

An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD

Blood and cerebrospinal fluid immune cell profiles in patients with temporal lobe epilepsy of different etiologies.

Genetic determinants of the humoral immune response in MS

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

Cerebrospinal fluid concentrations of neuronal proteins are reduced in primary angiitis of the central nervous system

Therapie und Verlauf neurologischer Erkrankungen

Therapie und Verlauf neurologischer Erkrankungen

Therapie und Verlauf neurologischer Erkrankungen

Fragen und Antworten zur Neuroimmunologie

Impaired Autonomic Responses to Emotional Stimuli in Autoimmune Limbic Encephalitis

Excitotoxic neuronal cell death during an oligodendrocyte-directed CD8+T cell attack in the CNS gray matter

Alemtuzumab : humanisierter monoklonaler Antikörper in der MS-Therapie